|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tabrizian P, Jibara G, Shrager B, Schwartz
M and Roayaie S: Recurrence of hepatocellular cancer after
resection: Patterns, treatments, and prognosis. Ann Surg.
261:947–955. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Roundtree IA, Evans ME, Pan T and He C:
Dynamic RNA modifications in gene expression regulation. Cell.
169:1187–1200. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Adams JM and Cory S: Modified nucleosides
and bizarre 5′-termini in mouse myeloma mRNA. Nature. 255:28–33.
1975. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Camper SA, Albers RJ, Coward JK and
Rottman FM: Effect of undermethylation on mRNA cytoplasmic
appearance and half-life. Mol Cell Biol. 4:538–543. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Finkel D and Groner Y: Methylations of
adenosine residues (m6A) in pre-mRNA are important for formation of
late simian virus 40 mRNAs. Virology. 131:409–425. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gilbert WV, Bell TA and Schaening C:
Messenger RNA modifications: Form, distribution, and function.
Science. 352:1408–1412. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma S, Chen C, Ji X, Liu J, Zhou Q, Wang G,
Yuan W, Kan Q and Sun Z: The interplay between m6A RNA methylation
and noncoding RNA in cancer. J Hematol Oncol. 12:1212019.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Allis CD and Jenuwein T: The molecular
hallmarks of epigenetic control. Nat Rev Genet. 17:487–500. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Du H, Zhao Y, He J, Zhang Y, Xi H, Liu M,
Ma J and Wu L: YTHDF2 destabilizes m(6)A-containing RNA through
direct recruitment of the CCR4-NOT deadenylase complex. Nat Commun.
7:126262016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang X, Zhao BS, Roundtree IA, Lu Z, Han
D, Ma H, Weng X, Chen K, Shi H and He C: N(6)-methyladenosine
modulates messenger RNA translation efficiency. Cell.
161:1388–1399. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen J, Sun Y, Xu X, Wang D, He J, Zhou H,
Lu Y, Zeng J, Du F, Gong A and Xu M: YTH domain family 2
orchestrates epithelial-mesenchymal transition/proliferation
dichotomy in pancreatic cancer cells. Cell Cycle. 16:2259–2271.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nishizawa Y, Konno M, Asai A, Koseki J,
Kawamoto K, Miyoshi N, Takahashi H, Nishida N, Haraguchi N, Sakai
D, et al: Oncogene c-Myc promotes epitranscriptome m6A
reader YTHDF1 expression in colorectal cancer. Oncotarget.
9:7476–7486. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shi Y, Fan S, Wu M, Zuo Z, Li X, Jiang L,
Shen Q, Xu P, Zeng L, Zhou Y, et al: YTHDF1 links hypoxia
adaptation and non-small cell lung cancer progression. Nat Commun.
10:48922019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han
D, Fu Y, Parisien M, Dai Q, Jia G, et al:
N6-methyladenosine-dependent regulation of messenger RNA stability.
Nature. 505:117–120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li J, Xie H, Ying Y, Chen H, Yan H, He L,
Xu M, Xu X, Liang Z, Liu B, et al: YTHDF2 mediates the mRNA
degradation of the tumor suppressors to induce AKT phosphorylation
in N6-methyladenosine-dependent way in prostate cancer. Mol Cancer.
19:1522020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bai Y, Yang C, Wu R, Huang L, Song S, Li
W, Yan P, Lin C, Li D and Zhang Y: YTHDF1 regulates tumorigenicity
and cancer stem cell-like activity in human colorectal carcinoma.
Front Oncol. 9:3322019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Han J, Wang JZ, Yang X, Yu H, Zhou R, Lu
HC, Yuan WB, Lu JC, Zhou ZJ, Lu Q, et al: METTL3 promote tumor
proliferation of bladder cancer by accelerating pri-miR221/222
maturation in m6A-dependent manner. Mol Cancer. 18:1102019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin S, Choe J, Du P, Triboulet R and
Gregory RI: The m(6)A Methyltransferase METTL3 promotes translation
in human cancer cells. Mol Cell. 62:335–345. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Miao W, Chen J, Jia L, Ma J and Song D:
The m6A methyltransferase METTL3 promotes osteosarcoma progression
by regulating the m6A level of LEF1. Biochem Biophys Res Commun.
516:719–725. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Q, Chen C, Ding Q, Zhao Y, Wang Z,
Chen J, Jiang Z, Zhang Y, Xu G, Zhang J, et al: METTL3-mediated
m6A modification of HDGF mRNA promotes gastric cancer
progression and has prognostic significance. Gut. 69:1193–1205.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xia T, Wu X, Cao M, Zhang P, Shi G, Zhang
J, Lu Z, Wu P, Cai B, Miao Y and Jiang K: The RNA m6A
methyltransferase METTL3 promotes pancreatic cancer cell
proliferation and invasion. Pathol Res Pract. 215:1526662019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li J, Han Y, Zhang H, Qian Z, Jia W, Gao
Y, Zheng H and Li B: The m6A demethylase FTO promotes the growth of
lung cancer cells by regulating the m6A level of USP7 mRNA. Biochem
Biophys Res Commun. 512:479–485. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Niu Y, Lin Z, Wan A, Chen H, Liang H, Sun
L, Wang Y, Li X, Xiong XF, Wei B, et al: RNA N6-methyladenosine
demethylase FTO promotes breast tumor progression through
inhibiting BNIP3. Mol Cancer. 18:462019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang S, Zhao BS, Zhou A, Lin K, Zheng S,
Lu Z, Chen Y, Sulman EP, Xie K, Bögler O, et al: m6A
Demethylase ALKBH5 maintains tumorigenicity of glioblastoma
stem-like cells by sustaining FOXM1 expression and cell
proliferation program. Cancer Cell. 31:591–606.e6. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao X, Chen Y, Mao Q, Jiang X, Jiang W,
Chen J, Xu W, Zhong L and Sun X: Overexpression of YTHDF1 is
associated with poor prognosis in patients with hepatocellular
carcinoma. Cancer Biomark. 21:859–868. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qu N, Qin S, Zhang X, Bo X, Liu Z, Tan C,
Wen G and Jiang H: Multiple m6A RNA methylation
modulators promote the malignant progression of hepatocellular
carcinoma and affect its clinical prognosis. BMC Cancer.
20:1652020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang C, Huang S, Zhuang H, Ruan S, Zhou
Z, Huang K, Ji F, Ma Z, Hou B and He X: YTHDF2 promotes the liver
cancer stem cell phenotype and cancer metastasis by regulating OCT4
expression via m6A RNA methylation. Oncogene. 39:4507–4518. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhong L, Liao D, Zhang M, Zeng C, Li X,
Zhang R, Ma H and Kang T: YTHDF2 suppresses cell proliferation and
growth via destabilizing the EGFR mRNA in hepatocellular carcinoma.
Cancer Lett. 442:252–261. 2019. View Article : Google Scholar : PubMed/NCBI
|
